[Ssr2-review] ASK CLARIFICATION: Circulate link to ICANN technical portal and share links to relevant articles regarding threat mitigation and classification of threats.

Gannon, James-1 james-1.gannon at novartis.com
Wed May 24 08:12:51 UTC 2017


Yes should also be required reading!

James Gannon
Governance Manager – Global Strategic Projects & IT Security
Global Standards and Solutions

Novartis Ireland Ltd
Vista Building, Elm Park
Merrion Road
Dublin 4, Ireland
Office: +353-1-220-4370
Cell: +353-87-146-6195
James-1.Gannon at Novartis.com
-----Original Message-----
From: ssr2-review-bounces at icann.org [mailto:ssr2-review-bounces at icann.org] On Behalf Of David Conrad
Sent: 23 May 2017 19:59
To: James Gannon <james at cyberinvasion.net>
Cc: ssr2-review at icann.org
Subject: Re: [Ssr2-review] ASK CLARIFICATION: Circulate link to ICANN technical portal and share links to relevant articles regarding threat mitigation and classification of threats.

Or perhaps Dave's securityskeptic.com blog?

Regards,
-drc

> On May 23, 2017, at 11:28 AM, James Gannon <james at cyberinvasion.net> wrote:
>
> I think this was when Dave mentioned he had written some stuff on CircleID that might be relevant, if my memory serves me right?
>
> -James
>
> -----Original Message-----
> From: ssr2-review-bounces at icann.org [mailto:ssr2-review-bounces at icann.org] On Behalf Of Steve Conte
> Sent: 23 May 2017 19:27
> To: ssr2-review at icann.org
> Subject: [Ssr2-review] ASK CLARIFICATION: Circulate link to ICANN technical portal and share links to relevant articles regarding threat mitigation and classification of threats.
>
> Hi RT members,
>
> I’m working with my team to satisfy some of the outstanding asks that were directed at the Office of the CTO.  One of the items is the following:
>
> —> Circulate link to ICANN technical portal and share links to relevant articles regarding threat mitigation and classification of threats.
>
> I believe the link has already been provided but my team is asking for clarification about the links to relevant articles.  I believe this ask took place during Dave Piscitello’s presentation of the DART project.
>
> Thanks,
>
> Steve
>
>
> -----
> Steve Conte
> steve.conte at icann.org
>
>
>
> _______________________________________________
> Ssr2-review mailing list
> Ssr2-review at icann.org
> https://mm.icann.org/mailman/listinfo/ssr2-review
> _______________________________________________
> Ssr2-review mailing list
> Ssr2-review at icann.org
> https://mm.icann.org/mailman/listinfo/ssr2-review


Novartis Ireland Ltd.
Registered No. 11931, Ireland.
Registered Office: The Vista Building, Elm Park Business Park, Merrion Road, Dublin 4. DO4 A9N6, Ireland.

Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.


More information about the Ssr2-review mailing list